Endocannabinoids are endogenous ligands of cannabinoid receptors (CB1 and CB2) [33], and dysregulation of the endocannabinoid system has been associated with multiple health outcomes including cardiovascular disease, neurodegenerative disorders, and cancer [33]. Here, CNR2 is linked to cardiovascular disorder.